Showing results (271-280 of 312) with videos related to
Sort By:
Pageof 32
Urologic Oncology|October 11, 2023
HPV-positive clinically advanced squamous cell carcinoma of the urinary bladder (aBSCC): A comprehensive genomic profiling (CGP) studyG H Ghelani, M Bou Zerdan, J Jacob, et al.Development (Cambridge, England)|August 11, 2019
Lactate dehydrogenase and glycerol-3-phosphate dehydrogenase cooperatively regulate growth and carbohydrate metabolism during Drosophila melanogaster larval developmentHongde Li, Madhulika Rai, Kasun Buddika, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|April 5, 2018
Genetic Analysis of 779 Advanced Differentiated and Anaplastic Thyroid CancersNikita Pozdeyev, Laurie M Gay, Ethan S Sokol, et al.Cancers|July 20, 2021
Clinically Advanced Pheochromocytomas and Paragangliomas: A Comprehensive Genomic Profiling StudyGennady Bratslavsky, Ethan S Sokol, Michael Daneshvar, et al.Nature Communications|May 9, 2025
Ligand-activated EGFR/MAPK signaling but not PI3K, are key resistance mechanisms to EGFR-therapy in colorectal cancerXueping Qu, Habib Hamidi, Radia M Johnson, et al.Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 14, 2018
Loss of function of NF1 is a mechanism of acquired resistance to endocrine therapy in lobular breast cancerE S Sokol, Y X Feng, D X Jin, et al.Journal for Immunotherapy of Cancer|August 16, 2023
Real-world pan-cancer landscape of frameshift mutations and their role in predicting responses to immune checkpoint inhibitors in cancers with low tumor mutational burdenVaia Florou, Charalampos S Floudas, Asaf Maoz, et al.Biorxiv : the Preprint Server for Biology|December 16, 2024
Co-regulator activity of Mediator of DNA Damage Checkpoint 1 (MDC1) is associated with DNA repair dysfunction and PARP inhibitor sensitivity in lobular carcinoma of the breastJoseph L Sottnik, Madeleine T Shackleford, Camryn S Nesiba, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|May 29, 2020
CYLD-mutant cylindroma-like basaloid carcinoma of the anus: a genetically and morphologically distinct class of HPV-related anal carcinomaErik A Williams, Meagan Montesion, Radwa Sharaf, et al.Cancer Research|January 9, 2026
Altered MDC1 Interactions and Dysfunctional DNA Repair in Lobular Breast Cancer Confers Sensitivity to PARP InhibitionJoseph L Sottnik, Madeleine T Shackleford, Camryn S Nesiba, et al.Pageof 32